N-Cadherin Interacts with Axin and LRP5 To Negatively Regulate Wnt/β-Catenin Signaling, Osteoblast Function, and Bone Formation
暂无分享,去创建一个
R. Müller | T. Kohler | E. Laplantine | V. Geoffroy | M. Frain | P. Marie | E. Haÿ
[1] Ralph Müller,et al. Automated compartmental analysis for high-throughput skeletal phenotyping in femora of genetic mouse models. , 2007, Bone.
[2] Christof Niehrs,et al. Wnt Induces LRP6 Signalosomes and Promotes Dishevelled-Dependent LRP6 Phosphorylation , 2007, Science.
[3] R. Baron,et al. Wnt signaling and the regulation of bone mass , 2007, Current osteoporosis reports.
[4] G. Karsenty,et al. In vivo analysis of Wnt signaling in bone. , 2007, Endocrinology.
[5] W. Van Hul,et al. The genetics of low-density lipoprotein receptor-related protein 5 in bone: a story of extremes. , 2007, Endocrinology.
[6] B. Komm,et al. Wnt signaling and osteoblastogenesis , 2007, Reviews in Endocrine and Metabolic Disorders.
[7] Su‐Li Cheng,et al. Accentuated Ovariectomy‐Induced Bone Loss and Altered Osteogenesis in Heterozygous N‐Cadherin Null Mice , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[8] R. Civitelli,et al. Perspective: Cell–Cell Adhesion and Signaling Through Cadherins: Connecting Bone Cells in Their Microenvironment , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[9] O. MacDougald,et al. Regulation of bone mass by Wnt signaling. , 2006, The Journal of clinical investigation.
[10] S. Roman-Roman,et al. Wnt signalling pathway: a new target for the treatment of osteoporosis , 2005, Expert opinion on therapeutic targets.
[11] Xi He,et al. SOST Is a Ligand for LRP5/LRP6 and a Wnt Signaling Inhibitor* , 2005, Journal of Biological Chemistry.
[12] R. Baron,et al. Interaction between LRP5 and Frat1 Mediates the Activation of the Wnt Canonical Pathway* , 2005, Journal of Biological Chemistry.
[13] B. Geiger,et al. Signaling from adherens-type junctions. , 2005, European journal of cell biology.
[14] Su‐Li Cheng,et al. β‐Catenin and BMP‐2 synergize to promote osteoblast differentiation and new bone formation , 2005, Journal of cellular biochemistry.
[15] J. Westendorf,et al. Wnt signaling in osteoblasts and bone diseases. , 2004, Gene.
[16] Feng Cong,et al. Wnt signals across the plasma membrane to activate the β-catenin pathway by forming oligomers containing its receptors, Frizzled and LRP , 2004, Development.
[17] R. Nusse,et al. The Wnt signaling pathway in development and disease. , 2004, Annual review of cell and developmental biology.
[18] Su‐Li Cheng,et al. Targeted expression of a dominant-negative N-cadherin in vivo delays peak bone mass and increases adipogenesis , 2004, Journal of Cell Science.
[19] R. Krumlauf,et al. Connective-tissue growth factor modulates WNT signalling and interacts with the WNT receptor complex , 2004, Development.
[20] R. Nusse,et al. Convergence of Wnt, ß-Catenin, and Cadherin Pathways , 2004, Science.
[21] Xi He,et al. A mechanism for Wnt coreceptor activation. , 2004, Molecular cell.
[22] Keith R. Johnson,et al. Cadherin-mediated cellular signaling. , 2003, Current opinion in cell biology.
[23] Alison Rowe,et al. Wise, a context-dependent activator and inhibitor of Wnt signalling , 2003, Development.
[24] Yoshiaki Kawano,et al. Secreted antagonists of the Wnt signalling pathway , 2003, Journal of Cell Science.
[25] J. A. Robinson,et al. High Bone Mass in Mice Expressing a Mutant LRP5 Gene , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[26] Gideon A. Rodan,et al. Control of osteoblast function and regulation of bone mass , 2003, Nature.
[27] Eric Wieschaus,et al. Wg/Wnt signal can be transmitted through arrow/LRP5,6 and Axin independently of Zw3/Gsk3beta activity. , 2003, Developmental cell.
[28] J. Lilien,et al. PTP1B Modulates the Association of β-Catenin with N-cadherin through Binding to an Adjacent and Partially Overlapping Target Site* , 2002, The Journal of Biological Chemistry.
[29] L. Hofbauer,et al. High bone density due to a mutation in LDL-receptor-related protein 5. , 2002, The New England journal of medicine.
[30] Richard P Lifton,et al. High bone density due to a mutation in LDL-receptor-related protein 5. , 2002, The New England journal of medicine.
[31] Avri Ben-Ze'ev,et al. The cadherin-catenin adhesion system in signaling and cancer. , 2002, The Journal of clinical investigation.
[32] Ivan Lobov,et al. Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor , 2002, The Journal of cell biology.
[33] E. Wagner,et al. Reaching a genetic and molecular understanding of skeletal development. , 2002, Developmental cell.
[34] P. Marie. Role of N‐cadherin in bone formation , 2002, Journal of cellular physiology.
[35] V. Lefebvre,et al. Regulatory mechanisms in the pathways of cartilage and bone formation. , 2001, Current opinion in cell biology.
[36] Miikka Vikkula,et al. LDL Receptor-Related Protein 5 (LRP5) Affects Bone Accrual and Eye Development , 2001, Cell.
[37] Stuart A. Aaronson,et al. Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow , 2001, Nature Cell Biology.
[38] J. Lemonnier,et al. Role of N‐Cadherin and Protein Kinase C in Osteoblast Gene Activation Induced by the S252W Fibroblast Growth Factor Receptor 2 Mutation in Apert Craniosynostosis , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[39] J Mao,et al. Low-density lipoprotein receptor-related protein-5 binds to Axin and regulates the canonical Wnt signaling pathway. , 2001, Molecular cell.
[40] Su‐Li Cheng,et al. A Dominant Negative Cadherin Inhibits Osteoblast Differentiation , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[41] Kathleen E. Rankin,et al. Regulation of Glycogen Synthase Kinase 3β and Downstream Wnt Signaling by Axin , 1999, Molecular and Cellular Biology.
[42] J Mao,et al. Axin and Frat1 interact with Dvl and GSK, bridging Dvl to GSK in Wnt‐mediated regulation of LEF‐1 , 1999, The EMBO journal.
[43] J. Nathans,et al. A new secreted protein that binds to Wnt proteins and inhibits their activites , 1999, Nature.
[44] T. Akiyama,et al. Negative regulation of Wingless signaling by D-axin, a Drosophila homolog of axin. , 1999, Science.
[45] T. Bouwmeester,et al. The head inducer Cerberus is a multifunctional antagonist of Nodal, BMP and Wnt signals , 1999, Nature.
[46] S. Sokol,et al. Axis determination in Xenopus involves biochemical interactions of axin, glycogen synthase kinase 3 and β-catenin , 1998, Current Biology.
[47] Akira Kikuchi,et al. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK‐3β and β‐catenin and promotes GSK‐3β‐dependent phosphorylation of β‐catenin , 1998 .
[48] Wei Hsu,et al. The Mouse Fused Locus Encodes Axin, an Inhibitor of the Wnt Signaling Pathway That Regulates Embryonic Axis Formation , 1997, Cell.
[49] K. Linask,et al. N-cadherin-catenin interaction: necessary component of cardiac cell compartmentalization during early vertebrate heart development. , 1997, Developmental biology.
[50] B. de Crombrugghe,et al. Identification of a minimal sequence of the mouse pro-alpha 1(I) collagen promoter that confers high-level osteoblast expression in transgenic mice and that binds a protein selectively present in osteoblasts. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[51] M. Drezner,et al. Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[52] G. Karsenty,et al. Molecular bases of the regulation of bone remodeling by the canonical Wnt signaling pathway. , 2006, Current topics in developmental biology.
[53] Mark L. Johnson,et al. Parameters of LRP5 from a structural and molecular perspective. , 2005, Critical reviews in eukaryotic gene expression.
[54] R. Nusse,et al. Convergence of Wnt, beta-catenin, and cadherin pathways. , 2004, Science.
[55] Mark L. Johnson,et al. A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. , 2002, American journal of human genetics.
[56] P. Marie. The Molecular Genetics of Bone Formation , 2001, American journal of pharmacogenomics : genomics-related research in drug development and clinical practice.
[57] J. Lemonnier,et al. N- and E-cadherin mediate early human calvaria osteoblast differentiation promoted by bone morphogenetic protein-2. , 2000, Journal of cellular physiology.
[58] A. Kikuchi,et al. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. , 1998, The EMBO journal.